AIDS Research and Human Retroviruses · 1993 · 34 citations · 24 references
Life SciencesInfectious DiseasesMolecular BiologyCellular ImmunologyMolecular VirologyMonoclonal AntibodiesAntibody CharacterizationAntiviral ImmunityAntibody-mediated Viral NeutralizationAntibody-mediated Virus NeutralizationCd4 Positive T CellsChinese Hamster Ovary CellsCombination TherapyPolyclonal AntibodiesViral Fusion InhibitorsViral Fusion Proteins
CD4-based molecules were tested in combination with HIV-1-neutralizing antibodies directed against the V3 loop of gp120 or against gp41, for inhibition of HIV-1 envelope-mediated cell fusion. A virus-free cell fusion assay was developed, using Chinese hamster ovary cells that stably express HIV-1 gp120/gp41. These cells were incubated with dilutions of CD4-based molecules, antibodies, or mixtures of both, then overlaid with C8166 CD4+ T cells. Syncytia were counted and the degree of inhibition of cell fusion was determined. Synergy, additivity, or antagonism was calculated by the combination index (CI) method. The CD4-based molecules included soluble human CD4 as well as fusion proteins composed of CD4 linked to human immunoglobulin gamma 1 or gamma 2 heavy chains. Combinations of CD4-based molecules and monoclonal or polyclonal anti-V3 loop antibodies were synergistic in blocking HIV-1 envelope-mediated cell fusion (CI = 0.21-0.91 at 95% inhibition). Synergy was also observed with combinations of the CD4-based molecules and a broadly neutralizing anti-gp41 monoclonal antibody (2F5) (CI = 0.29-0.65 at 95% inhibition). These results demonstrate that molecules inhibiting HIV attachment act synergistically with molecules inhibiting HIV-1 fusion. The results suggest that CD4-based therapeutics would be more effective in patients with naturally occurring anti-V3 loop or anti-gp41 antibodies. In addition, there may be an advantage in coadministering CD4-based molecules and antibodies that block fusion, especially broadly neutralizing anti-gp41 antibodies, as a combination therapy for HIV-1 infections.
24
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity
Joseph Sodroski, Wei Chun Goh, C A Rosen et al. · Nature · 1986 · 800 citations
M Tersmette, Rob A. Gruters, F. de Wolf et al. · Journal of Virology · 1989 · 639 citations · Full text
J R Rusche, Kashi Javaherian, Charlene McDanal et al. · Proceedings of the National Academy of Sciences · 1988 · 623 citations · Full text